Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Computational and Mathematical Methods in Medicine
Volume 2014, Article ID 182935, 7 pages
http://dx.doi.org/10.1155/2014/182935
Research Article

Impact of Dose and Sensitivity Heterogeneity on TCP

1Medical Radiation Physics, Stockholm University, 106 91 Stockholm, Sweden
2Department of Oncology and Pathology, Karolinska Institutet, P.O. Box 260, 171 76 Stockholm, Sweden

Received 15 January 2014; Accepted 15 April 2014; Published 12 May 2014

Academic Editor: Chris Bauch

Copyright © 2014 Kristin Wiklund et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Brahme and A.-K. Agren, “Optimal dose distribution for eradication of heterogeneous tumors,” Acta Oncologica, vol. 26, no. 5, pp. 377–385, 1987. View at Google Scholar · View at Scopus
  2. S. Webb and A. E. Nahum, “A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density,” Physics in Medicine and Biology, vol. 38, no. 6, article 001, pp. 653–666, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Niemierko and M. Goitein, “Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor,” Radiotherapy and Oncology, vol. 29, no. 2, pp. 140–147, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Goitein, “Causes and consequences of inhomogeneous dose distributions in radiation therapy,” International Journal of Radiation Oncology Biology Physics, vol. 12, no. 4, pp. 701–704, 1986. View at Google Scholar · View at Scopus
  5. S. Webb, “Optimum parameters in a model for tumour control probability including interpatient heterogeneity,” Physics in Medicine and Biology, vol. 39, no. 11, pp. 1895–1914, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. B. K. Lind and A. Brahme, “The effect on tumor control probability due to inter-patient variabitliy in sensitivity and clonogen number,” in Proceedings of the 12th ICCR, Medical Physics Publishing, Madison, Wis, USA, 1997.
  7. J. D. Fenwick, “Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression,” Physics in Medicine and Biology, vol. 43, no. 8, pp. 2159–2178, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Roberts and J. H. Hendry, “A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity,” International Journal of Radiation Oncology Biology Physics, vol. 41, no. 3, pp. 689–699, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Roberts and J. H. Hendry D.sc, “Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers,” International Journal of Radiation Oncology Biology Physics, vol. 45, no. 5, pp. 1247–1257, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Sanchez-Nieto and A. E. Nahum, “The delta-TCP concept: a clinically useful measure of tumor control probability,” International Journal of Radiation Oncology Biology Physics, vol. 44, no. 2, pp. 369–380, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. F. M. Buffa and A. E. Nahum, “Monte Carlo dose calculations and radiobiological modelling: analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control,” Physics in Medicine and Biology, vol. 45, no. 10, pp. 3009–3023, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Daşu, I. Toma-Daşu, and J. F. Fowler, “Should single or distributed parameters be used to explain the steepness of tumour control probability curves?” Physics in Medicine and Biology, vol. 48, no. 3, pp. 387–397, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Harting, P. Peschke, and C. P. Karger, “Computer simulation of tumour control probabilities after irradiation for varying intrinsic radio-sensitivity using a single cell based model,” Acta Oncologica, vol. 49, no. 8, pp. 1354–1362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. L. Tucker, H. D. Thames, and J. M. G. Taylor, “How well is the probability of tumor cure after fractionated irradiation described by poisson statistics?” Radiation Research, vol. 124, no. 3, pp. 273–282, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Y. Yakovlev, “Comments on the distribution of clonogens in irradiated tumors,” Radiation Research, vol. 134, no. 1, pp. 117–120, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. W. S. Kendal, “Technical report: a closed form description of tumour control with fractionated radiotherapy and repopulation,” International Journal of Radiation Biology, vol. 73, no. 2, pp. 207–210, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Deasy, “Poisson formulas for tumor control probability with clonogen proliferation,” Journal of Radiation Research, vol. 145, pp. 382–384, 1996. View at Google Scholar
  18. S. L. Tucker and J. M. Taylor, “Improved models of tumour cure,” International Journal of Radiation Biology, vol. 70, pp. 539–553, 1996. View at Google Scholar
  19. M. Zaider and G. N. Minerbo, “Tumour control probability: a formulation applicable to any temporal protocol of dose delivery,” Physics in Medicine and Biology, vol. 45, no. 2, pp. 279–293, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. L. G. Hanin, M. Zaider, and A. Y. Yakovlev, “Distribution of the number of clonogens surviving fractionated radiotherapy: a long-standing problem revisited,” International Journal of Radiation Biology, vol. 77, no. 2, pp. 205–213, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Wiklund, I. Toma-Dasu, and B. K. Lind, “The influence of dose heterogeneity on tumour control probability in fractionated radiation therapy,” Physics in Medicine and Biology, vol. 56, no. 23, pp. 7585–7600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Toma-Daşu, A. Daşu, and A. Brahme, “Dose prescription and optimisation based on tumour hypoxia,” Acta Oncologica, vol. 48, no. 8, pp. 1181–1192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Brenner, “Dose, volume, and tumor-control predictions in radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 26, no. 1, pp. 171–179, 1993. View at Google Scholar · View at Scopus